Fact CheckerSign in

NCT06363617Completed

Implementation of the Fatty Liver Index in Primary Care

Implementation of the Fatty Liver Index in Primary Care for Patients at Risk of Hepatic Steatosis to Optimize Clinical Control: Randomized Clinical Trial

Source: ClinicalTrials.gov · Last updated 29 Jun 2025

Brief summary (registry, in English)

This trial aims to evaluate the impact on cardiovascular risk control in individuals in risk of being affected by hepatic steatosis through the implementation of a screening test (Fatty Liver Index) in Primary Care. Medical teams in a primary care center will be divided into 2 groups, with one group using the screening test in their clinical practice. The number of interventions on cardiovascular risk occurring in patients attended by each group of medical teams will be evaluated and compared.

Status (registry)
Completed
Study type
Interventional
Enrollment
434 (actual)
First submitted
9 Apr 2024
Start date
2 May 2024
Primary completion date
1 Feb 2025
Lead sponsor
Consorci Sanitari de l'Alt Penedès i Garraf
Diseases
Obesity
NCT number
NCT06363617

What you commit to

  • Study type: Interventional
  • Participants enrolled: 434
  • From 2 May 2024 to the primary completion date, 1 Feb 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Participants diagnosed with any of the following pathologies: Chronic liver diseases, including hepatic steatosis; Dementia; Active oncological diseases

Other

  • Pregnant women
  • Alcohol consumption habit (Standard Drink Unit (SDU); one SDU equals 10 grams of alcohol. Risky consumption is considered from 4 SDUs in men and 2 SDUs in women).
  • Displaced patients not assigned to the study center.
  • Patients classified as Advanced Chronic Care Model or Complex Chronic Patient.
  • Cognitive or affective pathology that limits the ability to collaborate with lifestyle interventions carried out at the center.
  • Patients under the care of endocrinology specialists.
  • Participation in another clinical trial involving an experimental intervention during the period of this trial.

Who the study is looking for

  • Men and women aged 14 years and older.
  • Attended at the Basic Care Units (BCU) participating in the Primary Care Center Baix a Mar study.
  • Intention to undergo medical follow-up at the study center.
  • Body mass index ≥ 25.

Age in the registry: 14 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Centro de Salud Vilanova i la Geltrú 3 Baix A Mar
Coordinator of this site? Confirm its status
Vilanova i la GeltrúSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.